With the identification of candidate podocyte antigen targets such as PLA2R and THSD7A and their respective PLA2R and anti-THSD7A autoantibodies, the autoimmune basis of MGN has effectively been established. This evidence concerns the gene THSD7A and idiopathic membranous glomerulonephritis.